Clinical Trials Directory

Trials / Completed

CompletedNCT02065648

Syngo NATIVE Contrast Enhanced 3D MRA on 3T Verio Magnet

NATIVE Sequence for Non-Contrast MR Angiogram Compared With Conventional Contrast Enhanced 3D MRA on 3T Verio Magnet

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
Cedars-Sinai Medical Center · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to compare non-contrast abdominal MR Angiogram (MRA) syngo NATIVE sequence performed on a 3T Verio Siemens magnet to a standard contrast-enhanced MRA performed as part of routine clinical care in patients with normal renal function to determine if the non-contrast NATIVE sequence is a viable alternative to contrast enhanced MRA in patients with renal insufficiency. There are no interventions--this is an observational study.

Detailed description

If the NATIVE sequence proves to be a viable alternative to contrast enhanced MRA it will provide imaging physicians with the diagnostic tool to assess vascular disease in patients with renal insufficiency without placing them at risk for additional co-morbidities.

Conditions

Timeline

Start date
2012-05-01
Primary completion
2015-03-01
Completion
2015-03-01
First posted
2014-02-19
Last updated
2025-02-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02065648. Inclusion in this directory is not an endorsement.